Conservative approach to massive haemoperitoneum of ovarian origin during anticoagulant therapy.
Recurrent massive haemoperitoneum of ovarian origin during anticoagulant therapy in a patient with mitral valve prosthesis is described. The patient was treated conservatively on both occasions. The authors suggest that a trial of conservative approach may be considered in such patients.
Lurie
S
S
Department of Obstetrics and Gynaecology, Kaplan Hospital, Rehovot, Israel.
Katz
Z
Z
Konichezky
S
S
Borenstein
R
R
D000328:Adult; D001803:Blood Transfusion; D003338:Corpus Luteum / Q000187:drug effects; D017707:Erythrocyte Transfusion; D005260:Female; D006350:Heart Valve Prosthesis; D006465:Hemoperitoneum / Q000139:chemically induced / Q000628:therapy*; D006801:Humans; D008943:Mitral Valve; D012214:Rheumatic Heart Disease / Q000188:drug therapy*; D014859:Warfarin / Q000009:adverse effects*
D014859:Warfarin